Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMWIVS9)

Drug Name

ISIS 330012 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting CRP messenger RNA (CRP mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ISIS-CRPRx	DML84CN	Coronary artery disease	BA80	Phase 2	[2]
ISIS-CRP	DMQDUG4	Cardiovascular disease	BA00-BE2Z	Phase 1	[3]
ISIS 133726	DMJ56XU	Discovery agent	N.A.	Investigative	[1]
ISIS 133712	DMDZ3FU	Discovery agent	N.A.	Investigative	[1]
ISIS 140180	DMP9WOZ	Discovery agent	N.A.	Investigative	[1]
ISIS 330031	DM35WFL	Discovery agent	N.A.	Investigative	[1]
ISIS 329956	DMA96KW	Discovery agent	N.A.	Investigative	[1]
Phosphocholine	DMIZLVW	Discovery agent	N.A.	Investigative	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	US patent application no. 7,425,545, Modulation of C-reactive protein expression.
2	Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies. J Pharmacol Toxicol Methods. 2014 Jan-Feb;69(1):49-60.
3	Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2009).
4	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.